[HTML][HTML] Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable …

…, L Liu, R Li, X Duan, Z Ma, J Yue, C Chen… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background Esophageal squamous cell carcinoma (ESCC) is one of the most refractory
malignant tumors. Esophageal cancer (EC) is a malignant tumor with a high incidence …

[HTML][HTML] Pembrolizumab combined with neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy followed by surgery for locally advanced oesophageal …

…, C Zhang, J Yue, X Duan, Z Ma, C Chen… - Frontiers in …, 2022 - frontiersin.org
Background: To compare the efficacy and safety of pembrolizumab combined with neoadjuvant
chemotherapy (neoCT) versus neoadjuvant chemoradiotherapy (neoCRT) followed by …

Safety and efficacy of Apatinib monotherapy for Unresectable, metastatic esophageal cancer: a single‐arm, open‐label, phase II study

…, P Tang, X Shang, Q Pang, D Liu, C Chen… - The …, 2020 - academic.oup.com
Lessons Learned Patient compliance with the oral dosage treatment was good, with no
need for hospitalization. Patients with tracheal and esophageal fistulas can take crushed …

[HTML][HTML] The assessment of intraoperative technique-related risk factors and the treatment of anastomotic leakage after esophagectomy: a narrative review

C Chen, H Jiang - Journal of gastrointestinal oncology, 2021 - ncbi.nlm.nih.gov
Anastomotic leakage, including cervical anastomotic leakage and intrathoracic anastomotic
leakage, is a serious complication of esophageal cancer and a leading cause of death after …

The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma

C Chuangui, T Peng, Y Zhentao - Pathology & Oncology Research, 2012 - Springer
The objective is to explore the expression of high mobility group box 1 (HMGB1) in esophageal
squamous cell carcinoma (ESCC) and its relationship with lymph node metastasis and …

[HTML][HTML] Lymph node dissection around left recurrent laryngeal nerve: robot-assisted vs. video-assisted McKeown esophagectomy for esophageal squamous cell …

X Duan, J Yue, C Chen, L Gong, Z Ma, X Shang… - Surgical …, 2021 - Springer
Objective This study investigated the advantages of robot-assisted McKeown esophagectomy
(RAME) for extensive superior mediastinal lymph node dissection (LND) versus video-…

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma …

D Qian, X Chen, X Shang, Y Wang, P Tang… - Radiotherapy and …, 2022 - Elsevier
Background and purpose More than 40% of patients with esophageal squamous cell
carcinoma (ESCC) exhibit pathological complete responses (pCR) after neoadjuvant …

[HTML][HTML] A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma

X Duan, X Shang, J Yue, Z Ma, C Chen, P Tang… - BMC cancer, 2021 - Springer
Background A nomogram was developed to predict lymph node metastasis (LNM) for patients
with early-stage esophageal squamous cell carcinoma (ESCC). Methods We used the …

Tumor marker index based on preoperative SCC and CYFRA 21-1 is a significant prognostic factor for patients with resectable esophageal squamous cell carcinoma

Y Qiao, C Chen, J Yue, Z Yu - Cancer Biomarkers, 2019 - content.iospress.com
OBJECTIVE : The aim of this study was to evaluate the prognostic value of a novel tumor
marker index (TMI) based on preoperative serum levels of squamous cell carcinoma antigen (…

[HTML][HTML] Comparison of lymph node metastasis pattern from esophagogastric junction adenocarcinoma versus very low thoracic esophageal squamous cancer: a …

Z Ma, C Chen, X Shang, J Yue… - Journal of Thoracic …, 2023 - ncbi.nlm.nih.gov
Background The anatomical locations of esophagogastric junction adenocarcinoma (AEG)
and very low thoracic esophageal squamous cell carcinoma (ESCC) are similar. This study …